Our Innovative Approaches
Our extensive database of Principal Investigators, leading hospitals, and research centres allows us to access special populations to fulfil your protocol requirements and ensure rapid recruitment of eligible study subjects.
For Clinical Trials in India, we offer site management services, project management, and patient recruitment strategies. Along with our innovative approaches, creative problem-solving, and dedicated professionals, HRAPLs’ transparency in operations is a key factor in building quality and trust with our clients. Our robust information delivery system allows us to provide clients with on-demand access to critical data.
Meet Our Team
Dr. Pradnya Anil Mahatme is the dynamic leader in charge of Clinical Operations at Hector Research and Archival Pvt. Ltd. (HRAPL) an emergent Site Management Organization (SMO) in India. Before this, she played an instrumental role as the Head of the Start-up department at GDD Experts, a US-based SMO, where she also took on the roles of Project Manager and Director. Dr. Pradnya boasts an impressive educational background, holding a Doctoral Degree in Clinical Biochemistry and a Diploma in Clinical Research. With over 16 years of professional experience in the field of Clinical Research, she possesses a profound knowledge of Clinical Biochemistry in relation to the conditions under investigation. Her leadership transcends professional boundaries, as she serves as a mentor, guiding the next generation of clinical researchers, and as an inspirational figure, driving excellence among her peers. Dr. Pradnya’s profound influence extends throughout the tapestry of clinical research in India, where she stands as a luminary, shaping the landscape with her dedication to advancing medical science.
Project Management Team
- Highly experienced and responsive.
- Impeccable track record for delivery on time and with quality.
- 5-25 years’ experience in the pharmaceutical industry, including long-term cohesiveness of the management team.
- Experience with all phases of clinical trials (Phase I -IV) across multiple therapeutic areas, in both paper and EDC environments.
HRAPL Advantages
- Rapid enrolment.
- Quick query resolution.
- Expedited site initiations.
- Expedited Timelines based.
- Efficient on-site monitoring.
- Speed of Execution: Flat structure and global locations, allows around-the-clock execution of priority activities.
- Flexibility: Ability to adapt internal processes to ensure timely execution of sponsor’s requirements.
- Financial Advantage: Project-specific efficiencies significantly reduce overall budgets.
- Key Therapeutic Area Knowledge and expertise via strong training programs.
- Quality: Activities conform to DCG(I), EMA, FDA requirements.
- Data entry: Highly experienced and responsive team with experience across all study phases, offering high quality and timely EDC entry ensures cost-effective management.
Cumulative years of experience
No. of Studies
No. of Audit and Inspections
Frequently Asked Questions
WHY ARE CLINICAL TRIALS DONE?
Many clinical trials are done to see if a new drug or device is safe and effective for people to use. Clinical trials are also done for other reasons. Some compare existing treatments to determine which is better. The current, approved treatments are called the “standard treatments.” Sometimes clinical trials are used to study different ways to use the standard treatments so they will be more effective, easier to use, and/or decrease side effects. Sometimes, studies are done to learn how to best use the treatment in a different population, such as children, in whom the treatment was not previously tested.
WHERE CAN PEOPLE FIND OUT ABOUT CLINICAL TRIALS?
People can find information about clinical trials now being conducted now by searching clinicaltrials.gov. ClinicalTrials.gov is an interactive online database, managed by the National Library of Medicine. It provides information about both federally and privately supported clinical research in human volunteers. ClinicalTrials.gov is updated regularly and offers information on each trial’s purpose, who is eligible to participate, locations, and phone numbers to call for more information.